Duodopa (levodopa/carbidopa intraduodenal gel infusion) / AbbVie  >>  Phase 4
Welcome,         Profile    Billing    Logout  

9 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Duodopa (levodopa/carbidopa intraduodenal gel infusion) / AbbVie
NCT00888186 / 2007-004985-41: Different Dyskinesias in Parkinson's Disease and Their Relation to Levodopa Pharmacokinetics

Completed
4
5
Europe
levodopa/carbidopa, Duodopa
Uppsala University, Swedish Parkinson's Disease Foundation, Swedish Society for Medical Research
Parkinson Disease, Dyskinesias
05/08
05/08
NCT00272688: Continuous Delivery of Levodopa in Patients With Advanced Idiopathic Parkinsons Disease - Cost-benefit

Completed
4
10
Europe
Levodopa (drug), intraduodenal administration
University Hospital, Akershus, Solvay Pharmaceuticals
Parkinson Disease
05/09
05/09
DuoCOMT, NCT00906828: Pharmacokinetics of Levodopa/Carbidopa Infusion With and Without Oral Catechol-O-methyl Transferase (COMT) Inhibitors

Checkmark AAN-2012 Data
Mar 2012 - Mar 2012: AAN-2012 Data
Completed
4
10
Europe
levodopa/carbidopa, Duodopa, entacapone, Comtess, Comtan., tolcapone, Tasmar
Uppsala University, Swedish Parkinson's Disease Foundation, Swedish Society for Medical Research
Parkinson Disease
11/09
11/09
NCT00914134: Duodenal Levodopa Infusion, Quality of Life and Autonomic Nervous System in Parkinson's Disease

Completed
4
12
Europe
Levodopa infusion, Duodopa
University of Helsinki, Solvay Pharmaceuticals
Parkinson's Disease
01/11
01/11
DAPHNE, NCT00141518 / 2005-002654-21: Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic Impact

Completed
4
77
Europe
Levodopa-carbidopa intestinal gel (LCIG), DUOPA™ (carbidopa and levodopa Enteral Suspension), DUODOPA®, ABT-SLV187, CADD-Legacy® 1400 ambulatory infusion pump, percutaneous endoscopic gastrostomy tube (PEG tube), jejunal extension tube (J-tube)
AbbVie (prior sponsor, Abbott)
Advanced Idiopathic Parkinson's Disease
03/11
04/11
2015-002631-17: A study comparing immediate-release oral Levodopa and L-dopa/carbidopa intestinal gel over cognition and mood in non-demented Parkinson?s disease (PD) patients Estudio de comparación de levodopa de liberación inmediata (IR-LD) y gel intestinal de L-dopa/carbidopa (LCIG) en la cognición y humor en pacientes no dementes con enfermedad de Parkinson (EP)

Completed
4
18
Europe
Duodopa, Sinemet Plus, Intestinal gel, Tablet, Duodopa, Sinemet Plus
Institut de Recerca del Hospital de la Santa Creu i Sant Pau, Abbvie Inc
Parkinson disease Enfermedad de Parkinson, Parkinson disease Enfermedad de Parkinson, Diseases [C] - Nervous System Diseases [C10]
 
 
2008-003581-26: Pharmacokinetics of levodopa using duodenal levodopa/carbidopa infusion with and without oral COMT inhibitors

Ongoing
4
10
Europe
Duodopa, Comtess, Tasmar, Duodopa, Comtess, Tasmar
Dept of Neuroscience, Uppsala University
Parkinson\'s disease (G20.9), advanced, patients presently on Duodopa treatment.
 
 
2008-003225-16: Aivostimulaattorin ja levodopainfuusion vaikutus elämänlaatuun ja autonomisen hermoston toimintaan Parkinsonin tautia sairastavilla potilailla

Completed
4
60
Europe
Duodopa
Organisation name was not entered
Vaikeahoitoinen Parkinsonin tauti potilailla, joille on aiemmin asetettu aivostimulaattori, tai on päädytty päivittäisten oireiden vuoksi aloittamaan Duodopa-infuusio.
 
09/14
INVEST, NCT02480803 / 2014-004501-32: INfusion VErsus STimulation in Parkinson's Disease

Completed
4
51
Europe
Continuous intrajejunal infusion of levodopa-carbidopa, Duodopa infusion, Intestinal levodopa-carbidopa infusion, deep brain stimulation, DBS, DBS-STN
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), ZonMw: The Netherlands Organisation for Health Research and Development
Parkinson's Disease
12/21
01/24

Download Options